Onsero Therapeutics

Onsero is a biotechnology company focused on developing innovative therapeutics for the treatment of complex mental illnesses. The company leverages recent advances in molecular biology and biochemistry to harness the neurobiology of the 5 HT 2A serotonin receptor, which is crucial for learning, cognition, memory, and other mental processes. Onsero's drug discovery engine targets this receptor to create a new class of pharmaceuticals aimed at providing rapid and sustained benefits beyond current treatment standards. The company primarily serves patients suffering from mental health disorders, operating in the biopharmaceutical market. Onsero's business model involves the research and development of these novel therapeutics, which it aims to commercialize through partnerships and direct sales. Revenue is generated through licensing agreements, milestone payments, and eventual product sales.

Keywords: biotechnology, therapeutics, mental illness, serotonin receptor, drug discovery, molecular biology, biochemistry, pharmaceuticals, innovation, neurobiology.